Literature DB >> 19372763

Activation of a unique p53-dependent DNA damage response.

Jun Yang, Afshan Ahmed, Margaret Ashcroft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19372763     DOI： 10.4161/cc.8.10.8326

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

Review 1.  p53-based cancer therapy.

Authors:  David P Lane; Chit Fang Cheok; Sonia Lain
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-12       Impact factor: 10.005

Review 2.  Awakening guardian angels: drugging the p53 pathway.

Authors:  Christopher J Brown; Sonia Lain; Chandra S Verma; Alan R Fersht; David P Lane
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

3.  Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.

Authors:  A Ahmed; J Yang; A Maya-Mendoza; D A Jackson; M Ashcroft
Journal:  Cell Death Dis       Date:  2011-05-19       Impact factor: 8.469

4.  RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38.

Authors:  A Weilbacher; M Gutekunst; M Oren; W E Aulitzky; H van der Kuip
Journal:  Cell Death Dis       Date:  2014-07-10       Impact factor: 8.469

5.  APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.

Authors:  Jun Hong; Zheng Chen; Dunfa Peng; Alexander Zaika; Frank Revetta; M Kay Washington; Abbes Belkhiri; Wael El-Rifai
Journal:  Oncotarget       Date:  2016-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.